Cargando…
Effective antitumor activity of 5T4‐specific CAR‐T cells against ovarian cancer cells in vitro and xenotransplanted tumors in vivo
Ovarian cancer is considered to be the most lethal gynecologic malignancy, and despite the development of conventional therapies and new therapeutic approaches, the patient's survival time remains short because of tumor recurrence and metastasis. Therefore, effective methods to control tumor pr...
Autores principales: | Guo, Cuiyu, Dong, E, Lai, Qinhuai, Zhou, Shijie, Zhang, Guangbing, Wu, Mengdan, Yue, Xiaozhu, Tao, Yiran, Peng, Yujia, Ali, Jamel, Lu, Ying, Fu, Yuyin, Lai, Weirong, Zhang, Zhixiong, Ma, Fanxin, Yao, Yuqin, Gou, Lantu, Yang, Hanshuo, Yang, Jinliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491242/ https://www.ncbi.nlm.nih.gov/pubmed/34766126 http://dx.doi.org/10.1002/mco2.34 |
Ejemplares similares
-
Targeting of DDR1 with antibody‐drug conjugates has antitumor effects in a mouse model of colon carcinoma
por: Tao, Yiran, et al.
Publicado: (2019) -
Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer
por: Zhang, Hang, et al.
Publicado: (2017) -
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
por: Fu, Yuyin, et al.
Publicado: (2021) -
Promiximab-duocarmycin, a new CD56 antibody-drug conjugates, is highly efficacious in small cell lung cancer xenograft models
por: Yu, Lin, et al.
Publicado: (2017) -
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma
por: Zhang, Guangbing, et al.
Publicado: (2022)